Abner Herrman & Brock LLC raised its position in Dow Chemical Co. (NYSE:DOW) by 38.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,357 shares of the company’s stock after buying an additional 10,305 shares during the period. Abner Herrman & Brock LLC’s holdings in Dow Chemical were worth $1,936,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of DOW. Stokes & Hubbell Capital Management LLC raised its stake in shares of Dow Chemical by 0.3% in the second quarter. Stokes & Hubbell Capital Management LLC now owns 5,965 shares of the company’s stock valued at $297,000 after buying an additional 16 shares during the last quarter. Capital Management Corp VA raised its stake in shares of Dow Chemical by 0.4% in the second quarter. Capital Management Corp VA now owns 4,433 shares of the company’s stock valued at $220,000 after buying an additional 16 shares during the last quarter. Gemmer Asset Management LLC raised its stake in shares of Dow Chemical by 0.3% in the second quarter. Gemmer Asset Management LLC now owns 6,248 shares of the company’s stock valued at $311,000 after buying an additional 19 shares during the last quarter. Mark Sheptoff Financial Planning LLC raised its stake in shares of Dow Chemical by 0.7% in the second quarter. Mark Sheptoff Financial Planning LLC now owns 2,938 shares of the company’s stock valued at $146,000 after buying an additional 19 shares during the last quarter. Finally, San Francisco Sentry Investment Group CA raised its stake in shares of Dow Chemical by 0.4% in the second quarter. San Francisco Sentry Investment Group CA now owns 5,337 shares of the company’s stock valued at $265,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 67.89% of the company’s stock.

Institutional Ownership by Quarter for Dow Chemical (NYSE:DOW)

Dow Chemical Co. (NYSE:DOW) traded down 0.61% during midday trading on Tuesday, hitting $53.99. The stock had a trading volume of 5,551,107 shares. The company has a market capitalization of $60.54 billion, a PE ratio of 8.41 and a beta of 1.20. The stock’s 50-day moving average is $53.70 and its 200-day moving average is $52.78. Dow Chemical Co. has a 1-year low of $40.26 and a 1-year high of $57.10.

Dow Chemical (NYSE:DOW) last released its quarterly earnings results on Thursday, October 27th. The company reported $0.91 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.12. The company earned $12.48 billion during the quarter, compared to analyst estimates of $12.01 billion. Dow Chemical had a return on equity of 17.81% and a net margin of 16.91%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $0.82 earnings per share. Equities research analysts forecast that Dow Chemical Co. will post $3.65 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Dow Chemical Co. (DOW) Stake Boosted by Abner Herrman & Brock LLC” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international copyright law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/29/dow-chemical-co-dow-stake-boosted-by-abner-herrman-brock-llc.html.

A number of analysts recently issued reports on DOW shares. Vetr upgraded Dow Chemical from a “strong sell” rating to a “sell” rating and set a $51.12 price objective on the stock in a research note on Monday, August 1st. RBC Capital Markets set a $65.00 price objective on Dow Chemical and gave the company a “buy” rating in a research note on Tuesday, September 20th. Citigroup Inc. upgraded Dow Chemical from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $55.00 to $59.00 in a research note on Monday, October 3rd. Zacks Investment Research upgraded Dow Chemical from a “hold” rating to a “buy” rating and set a $58.00 price objective on the stock in a research note on Wednesday, October 5th. Finally, Royal Bank Of Canada boosted their price objective on Dow Chemical from $65.00 to $68.00 and gave the company a “top pick” rating in a research note on Friday, October 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. Dow Chemical currently has a consensus rating of “Buy” and an average target price of $61.21.

Dow Chemical Company Profile

5 Day Chart for NYSE:DOW

Receive News & Stock Ratings for Dow Chemical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Co. and related stocks with our FREE daily email newsletter.